$HTGM HTG MOLECULAR DIAGNOSTICS, INC Insider Trading Week 19/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HTG MOLECULAR DIAGNOSTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in HTG MOLECULAR DIAGNOSTICS, INC in week 19/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | C | 14.00 | 28,436 | 398,104 | 28,436 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | C | 0.22 | 1,818,681 | 398,109 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 210,893 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | X | 0.00 | 210,893 | 0 | 210,893 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | X | 0.00 | 210,893 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 7,613,826 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 20,658,958 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 9,601,924 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 8,670,520 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Buy | P | 14.00 | 167,343 | 2,342,802 | 756,704 | 589.4 K to 756.7 K (+28.39 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Buy | J | 0.00 | 52,929 | 0 | 589,361 | 536.4 K to 589.4 K (+9.87 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Buy | J | 14.00 | 55,377 | 775,278 | 536,432 | 481.1 K to 536.4 K (+11.51 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Buy | C | 0.00 | 1,963 | 0 | 481,055 | 479.1 K to 481.1 K (+0.41 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Buy | C | 0.00 | 70,898 | 0 | 479,092 | 408.2 K to 479.1 K (+17.37 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Buy | C | 0.00 | 192,373 | 0 | 408,194 | 215.8 K to 408.2 K (+89.14 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Buy | C | 0.00 | 90,494 | 0 | 215,821 | 125.3 K to 215.8 K (+72.21 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Merck Capital Ventures LLC | 10% Owner | Buy | C | 0.00 | 125,327 | 0 | 125,327 | 0 to 125.3 K |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | VP, Finance & Admin ... | Option Exercise | C | 0.00 | 152,276 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | VP, Finance & Admin ... | Option Exercise | C | 0.00 | 114,207 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | VP, Finance & Admin ... | Buy | J | 0.00 | 356 | 0 | 2,836 | 2.5 K to 2.8 K (+14.35 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | VP, Finance & Admin ... | Buy | C | 0.00 | 1,417 | 0 | 2,480 | 1.1 K to 2.5 K (+133.30 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | McMeans Shaun D | VP, Finance & Admin ... | Buy | C | 0.00 | 1,063 | 0 | 1,063 | 0 to 1.1 K |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Option Exercise | C | 0.00 | 76,138 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Option Exercise | C | 0.00 | 228,414 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | J | 0.00 | 737 | 0 | 3,571 | 2.8 K to 3.6 K (+26.01 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | C | 0.00 | 708 | 0 | 2,834 | 2.1 K to 2.8 K (+33.30 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Lubniewski John L | Chief Business Offi ... | Buy | C | 0.00 | 2,126 | 0 | 2,126 | 0 to 2.1 K |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Option Exercise | C | 0.00 | 10,544 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Option Exercise | X | 0.00 | 10,544 | 0 | 10,544 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Option Exercise | X | 0.00 | 10,544 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Option Exercise | C | 0.00 | 60,910 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Option Exercise | C | 0.00 | 233,495 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Option Exercise | C | 0.00 | 221,631 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Buy | J | 0.00 | 791 | 0 | 5,718 | 4.9 K to 5.7 K (+16.05 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Buy | C | 0.00 | 98 | 0 | 4,927 | 4.8 K to 4.9 K (+2.03 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Buy | C | 0.00 | 567 | 0 | 4,829 | 4.3 K to 4.8 K (+13.30 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Buy | C | 0.00 | 2,174 | 0 | 4,262 | 2.1 K to 4.3 K (+104.12 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | JOHNSON TIM B | President & CEO | Buy | C | 0.00 | 2,088 | 0 | 2,088 | 0 to 2.1 K |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GRIMM DONALD W | Director | Option Exercise | A | 14.64 | 5,000 | 73,200 | 5,000 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Option Exercise | C | 0.00 | 7,646 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Option Exercise | C | 0.00 | 25,124 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Buy | J | 0.00 | 52 | 0 | 356 | 304 to 356 (+17.11 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Buy | C | 0.00 | 71 | 0 | 304 | 233 to 304 (+30.47 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Gordon Debra A | V.P. and Chief Lega ... | Buy | C | 0.00 | 233 | 0 | 233 | 0 to 233 |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | C | 0.00 | 126,535 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | X | 0.00 | 126,535 | 0 | 126,535 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | X | 0.00 | 126,535 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | C | 0.00 | 1,895,946 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Option Exercise | C | 0.00 | 574,212 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Buy | C | 0.00 | 1,178 | 0 | 144,366 | 143.2 K to 144.4 K (+0.82 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Buy | C | 0.00 | 21,180 | 0 | 143,188 | 122 K to 143.2 K (+17.36 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | George Harry A. | Director | Buy | C | 0.00 | 17,321 | 0 | 122,008 | 104.7 K to 122 K (+16.55 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Option Exercise | C | 14.00 | 21,246 | 297,444 | 21,246 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Option Exercise | C | 0.22 | 1,358,988 | 297,482 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Option Exercise | C | 0.00 | 6,091,062 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Option Exercise | C | 0.00 | 26,496,116 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | P | 14.00 | 102,445 | 1,434,230 | 518,595 | 416.2 K to 518.6 K (+24.62 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | J | 0.00 | 68,404 | 0 | 416,150 | 347.7 K to 416.2 K (+19.67 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | J | 14.00 | 44,301 | 620,214 | 347,746 | 303.4 K to 347.7 K (+14.60 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | C | 0.00 | 56,718 | 0 | 303,445 | 246.7 K to 303.4 K (+22.99 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | Fletcher Spaght Ventures II LP | 10% Owner | Buy | C | 0.00 | 246,727 | 0 | 246,727 | 0 to 246.7 K |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 43,538 | 0 | 43,538 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 2,784,593 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 110,755 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 15,227,653 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 36,546,366 | 0 | 0 | |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 110,755 | 0 | 1,049,243 | 938.5 K to 1 M (+11.80 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | J | 0.00 | 91,271 | 0 | 938,488 | 847.2 K to 938.5 K (+10.77 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 141,797 | 0 | 847,217 | 705.4 K to 847.2 K (+20.10 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 340,314 | 0 | 705,420 | 365.1 K to 705.4 K (+93.21 %) |
May 13 2015 | HTGM | HTG MOLECULAR DIAG ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 14.00 | 365,106 | 5,111,484 | 365,106 | 0 to 365.1 K |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | X | 0.00 | 49,786 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 110,755 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 156,123 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 598,415 | 0 | 0 | |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | P | 14.00 | 365,106 | 5,111,484 | 1,280,185 | 915.1 K to 1.3 M (+39.90 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | X | 0.00 | 49,786 | 0 | 915,079 | 865.3 K to 915.1 K (+5.75 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 110,755 | 0 | 865,293 | 754.5 K to 865.3 K (+14.68 %) |
May 12 2015 | HTGM | HTG MOLECULAR DIAG ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 754,538 | 0 | 754,538 | 0 to 754.5 K |